We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Cambridge Cognition Holdings plc (COG) Ordinary 1p

Sell:27.00p Buy:28.00p 0 Change: No change
Market closed Prices as at close on 3 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:27.00p
Buy:28.00p
Change: No change
Market closed Prices as at close on 3 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:27.00p
Buy:28.00p
Change: No change
Market closed Prices as at close on 3 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cambridge Cognition Holdings plc is a United Kingdom-based company, which is engaged in developing and marketing digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB, Electronic Clinical Outcomes Assessment (eCOA), NeuroVocalix, Winterlight, Cognition Kit, Clinpal, eConsent, and AQUA. CANTAB Connect gives the control to manage and deliver battery of touchscreen and voice assessments, as well as fully customizable electronic questionnaires and scales. The Company’s therapeutic areas include attention deficit hyperactivity disorder (ADHD), Alzheimer’s Disease, Autism Spectrum Disorder, Cognitive Safety, Core Cognitive Function, Depression, Down’s Syndrome, Drug Abuse Liability, Epilepsy, Huntington’s Disease, Multiple Sclerosis, Neuromuscular Disorders, Obsessive Compulsive Disorder, Parkinson’s Disease, Schizophrenia, Stroke and Cerebrovascular Disease, and Traumatic Brain Injury.

Contact details

Address:
Tunbridge Court
Tunbridge Lane, Bottisham
CAMBRIDGE
CB25 9TU
United Kingdom
Telephone:
+ (0)
Website:
https://www.cambridgecognition.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 22 August 2024 22/08/24
Trading Announcement 23 July 2024 23/07/24
AGM 28 June 2024 28/06/24
General meeting 17 June 2024 17/06/24
Annual report 06 June 2024 06/06/24
Final results 01 May 2024 01/05/24
Trading Announcement 01 May 2024 01/05/24
Trading Announcement 30 January 2024 30/01/24

General stock information

EPIC:
COG
ISIN:
GB00B8DV9647
Market cap:
£11.51 million
Shares in issue:
41.87 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Stephen Symonds
    Chief Financial Officer, Executive Director, Company Secretary
  • Francesca Cormack
    Chief Scientific Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.